An Open-label Extension to Study AVA102670 and AVA102672
DescriptionA forum to discuss or ask questions about an Open-label Extension to Study AVA102670 and AVA102672, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended-Release Tablets) as Adjunctive Therapy on Cognition in Subjects with Mild to Moderate
